These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 36314067

  • 21. Loss of transketolase promotes the anti-diabetic role of brown adipose tissues.
    Ji Y, Liu W, Zhu Y, Li Y, Lu Y, Liu Q, Tong L, Hu L, Xu N, Chen Z, Tian N, Wu L, Zhu L, Tang S, Zhang P, Tong X.
    J Endocrinol; 2023 Mar 01; 256(3):. PubMed ID: 36449405
    [Abstract] [Full Text] [Related]

  • 22. Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation.
    Li M, Zhao X, Yong H, Xu J, Qu P, Qiao S, Hou P, Li Z, Chu S, Zheng J, Bai J.
    Cell Death Dis; 2022 Feb 02; 13(2):99. PubMed ID: 35110545
    [Abstract] [Full Text] [Related]

  • 23. Transketolase of Staphylococcus aureus in the Control of Master Regulators of Stress Response During Infection.
    Tan X, Ramond E, Jamet A, Barnier JP, Decaux-Tramoni B, Dupuis M, Euphrasie D, Tros F, Nemazanyy I, Ziveri J, Nassif X, Charbit A, Coureuil M.
    J Infect Dis; 2019 Nov 06; 220(12):1967-1976. PubMed ID: 31420648
    [Abstract] [Full Text] [Related]

  • 24. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.
    Tong L, Chen Z, Li Y, Wang X, Yang C, Li Y, Zhu Y, Lu Y, Liu Q, Xu N, Shao S, Wu L, Zhang P, Wu G, Wu X, Chen X, Fang J, Jia R, Xu T, Li B, Zheng L, Liu J, Tong X.
    Cell Metab; 2024 May 07; 36(5):1013-1029.e5. PubMed ID: 38547864
    [Abstract] [Full Text] [Related]

  • 25. Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy.
    Zhen X, Zhang M, Hao S, Sun J.
    Biomed Pharmacother; 2024 Jul 07; 176():116935. PubMed ID: 38876050
    [Abstract] [Full Text] [Related]

  • 26. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.
    Wang S, Wang Y, Xun X, Zhang C, Xiang X, Cheng Q, Hu S, Li Z, Zhu J.
    J Exp Clin Cancer Res; 2020 Jan 28; 39(1):22. PubMed ID: 31992334
    [Abstract] [Full Text] [Related]

  • 27. Effect of transketolase modifications on carbon flow to the purine-nucleotide pathway in Corynebacterium ammoniagenes.
    Kamada N, Yasuhara A, Takano Y, Nakano T, Ikeda M.
    Appl Microbiol Biotechnol; 2001 Sep 28; 56(5-6):710-7. PubMed ID: 11601619
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
    Yuan W, Wu S, Guo J, Chen Z, Ge J, Yang P, Hu B, Chen Z.
    Cancer Biol Ther; 2010 May 01; 9(9):710-6. PubMed ID: 20200485
    [Abstract] [Full Text] [Related]

  • 31. A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
    Schneider S, Lüdtke S, Schröder-Tittmann K, Wechsler C, Meyer D, Tittmann K.
    PLoS One; 2012 May 01; 7(10):e48321. PubMed ID: 23118983
    [Abstract] [Full Text] [Related]

  • 32. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
    Oaks Z, Jimah J, Grossman CC, Beckford M, Kelly R, Banerjee S, Niland B, Miklossy G, Kuloglu Z, Kansu A, Lee W, Szonyi L, Banki K, Perl A.
    J Inherit Metab Dis; 2020 May 01; 43(3):496-506. PubMed ID: 31769880
    [Abstract] [Full Text] [Related]

  • 33. Cloning, expression and characterization of sugarcane (Saccharum officinarum L.) transketolase.
    Kalhori N, Nulit R, Go R.
    Protein J; 2013 Oct 01; 32(7):551-9. PubMed ID: 24132392
    [Abstract] [Full Text] [Related]

  • 34. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J.
    Acta Pharm Sin B; 2022 Feb 01; 12(2):558-580. PubMed ID: 35256934
    [Abstract] [Full Text] [Related]

  • 35. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
    Chen H, Wu D, Bao L, Yin T, Lei D, Yu J, Tong X.
    Biomed Pharmacother; 2019 Mar 01; 111():1353-1358. PubMed ID: 30841449
    [Abstract] [Full Text] [Related]

  • 36. Megacell phenotype and its relation to metabolic alterations in transketolase deficient strain of Bacillus pumilus.
    Srivastava RK, Jaiswal R, Panda D, Wangikar PP.
    Biotechnol Bioeng; 2009 Apr 01; 102(5):1387-97. PubMed ID: 19039788
    [Abstract] [Full Text] [Related]

  • 37. Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma.
    Yao J, Tang S, Shi C, Lin Y, Ge L, Chen Q, Ou B, Liu D, Miao Y, Xie Q, Tang X, Fei J, Yang G, Tian J, Zeng X.
    Autophagy; 2023 Apr 01; 19(4):1221-1238. PubMed ID: 36048765
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer.
    Zhang L, Huang Z, Cai Q, Zhao C, Xiao Y, Quan X, Tang C, Gao J.
    Front Med (Lausanne); 2022 Apr 01; 9():837143. PubMed ID: 35280908
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.